CTOs on the Move

Q S Pharma

www.qspharma.com

 
Q S Pharma LLC is a Marcus Hook, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.qspharma.com
  • 3 Chelsea Pkwy Ste 305
    Marcus Hook, PA USA 19061
  • Phone: 610.485.4270

Executives

Name Title Contact Details

Similar Companies

Olympus IMS

Olympus delivers the world’s leading-edge nondestructive inspection and measurement solutions by developing tools and technologies that enhance safety, security, quality, and productivity. Our most popular offerings include ultrasound, phased array, microscopy, optical metrology, remote visual inspection, eddy current and XRF and XRD analyzers. We’re looking to share solutions, news, and insights about test, analytical, measurement, and imaging instruments with other industry professionals from the worlds of aerospace, power generation, petrochemical, manufacturing, automotive, consumer products, and many more.

Mousera

Mousera is accelerating medical advancement by bringing 21st century technology into living systems research. We`re currently recruiting in software, machine learning, computer vision, distributed systems, and user experience, while looking for heads of our preclinical and customer organizations. Contact me to find out more.

Health Communication Connection

Health Communication Connection is a Vienna, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vivo Infusion

Vivo Infusion is a leading provider of accessible, affordable, and safe community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.